Massachusetts General Hospital was established to provide care to Boston's sick, regardless of socioeconomic status—an innovative idea in 1811. In the words of their founder, John Warren, MD, “When in distress, every man becomes their neighbor.” They subsequently became the first teaching hospital for Harvard University’s new medical school and have been redefining excellence in healthcare ever since. They have remained at the forefront of medicine by fostering a culture of collaboration, pushing the boundaries of medical research, educating the brightest medical minds and maintaining an unwavering commitment to the diverse community they were created to serve. They believe that because of diversity they excel, through inclusion they respect their community, and with a keen focus on equity they serve, heal, educate and innovate at the highest levels. Their first priority is the well-being of their patients—near and far. As a team they are able to maintain a singular focus on providing the highest quality, most compassionate care to each and every patient.

Cancer Research Ventures Ltd. engages in the business of research and experimental development on biotechnology. It provides medical products. The company is headquartered in London, the United Kingdom.

The Eli and Edythe L. Broad Institute of MIT and Harvard (/ˈbroʊd/), often referred to as the Broad Institute, is a biomedical and genomic research center located in Cambridge, Massachusetts, United States. The institute is independently governed and supported as a 501(c)(3) nonprofit research organization under the name Broad Institute Inc., and is partners with Massachusetts Institute of Technology, Harvard University, and the five Harvard teaching hospitals.

Discovery Genomics, Inc. provides gene therapy tools to cure diseases. It discover gene functions and deliver safe, long-lasting gene therapy. The firm's products include SB Therapeutics Gene Delivery System and Licenses. The company was founded by R. Scott McIvor, Perry B. Hackett, Stephen C. Ekker, and David A. Largaespada in 2000 and is headquartered in Minneapolis, MN.

Jinan Saier Biotechnology Co., Ltd., established on 2010-07-05, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;R&D and application of cell technology;Human stem cell technology development and application;Production of Class I Medical Devices;Sales of Class I Medical Devices;Medical Research and Experimental Development;Information Technology Consulting Services;Development of Human Gene Diagnosis and Therapy Technology(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Guangdong Iridium Gene Technology Co., Ltd., established on 2016-01-14, Business scope includes biological and genetic technology development,technical consulting,technology transfer,Technical Services;gene drug development,consult,Serve,transfer;Production of biological reagents and consumables(production outsourcing),Wholesale and retail;Instrumentation,electronic product,glassware,Wholesale and retail of experimental equipment and consumables.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shanghai Bode Gene Development Co., Ltd., established on 1998-03-22, Business scope includes bioengineering,Technology transfer in the field of genetic engineering expertise,technology development,technical consulting,Technical services and manufacture of related reagents and equipment,Sales;Bioengineering and Genetic Engineering Products,electronics,Chemical Products(In addition to dangerous goods)import and export business. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Genecast offers DNA testing of tumors and gene-based medicine guidance. The company claims expertise in lung, colon, liver and breast cancers. Genecast plans to use the proceeds for further research and clinical trials, as well as expanding distribution channels.

Peking Union Medical College Hospital, also known as Beijing Xiehe Hospital (Chinese: 北京协和医院), is a renowned general hospital in Beijing, China. It was founded in 1921 by Rockefeller Foundation and is affiliated to both Peking Union Medical College (PUMC) and Chinese Academy of Medical Sciences (CAMS). During the Cultural Revolution, it was renamed the "Anti-imperialist Hospital".

Hangzhou Tianfan Biotechnology Co., Ltd., established on 2016-12-21, Business scope includes technology development,technical consulting,Achievement transfer:Biotechnology,medical technology,medical technology;technology development,technical consulting:Biological product;online sale:glassware,First,Class II medical device,Chemical Products(Removal of hazardous chemicals and precursor chemicals),Equipment,Machinery Parts;Serve:account Serive,Medical information consultation.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)